190 related articles for article (PubMed ID: 38053512)
61. Prolonged gut microbial alterations in post-transplant survivors of allogeneic haematopoietic stem cell transplantation.
Hino A; Fukushima K; Kusakabe S; Ueda T; Sudo T; Fujita J; Motooka D; Takeda AK; Shinozaki NO; Watanabe S; Yokota T; Shibayama H; Nakamura S; Hosen N
Br J Haematol; 2023 May; 201(4):725-737. PubMed ID: 36468273
[TBL] [Abstract][Full Text] [Related]
62. Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation.
Severyn CJ; Siranosian BA; Kong ST; Moreno A; Li MM; Chen N; Duncan CN; Margossian SP; Lehmann LE; Sun S; Andermann TM; Birbrayer O; Silverstein S; Reynolds CG; Kim S; Banaei N; Ritz J; Fodor AA; London WB; Bhatt AS; Whangbo JS
JCI Insight; 2022 Apr; 7(7):. PubMed ID: 35239511
[TBL] [Abstract][Full Text] [Related]
63. The gut microbiota and graft-versus-host disease.
Fredricks DN
J Clin Invest; 2019 May; 129(5):1808-1817. PubMed ID: 31042160
[TBL] [Abstract][Full Text] [Related]
64. Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Margolis EB; Alfaro GM; Sun Y; Dallas RH; Allison KJ; Ferrolino J; Ross HS; Davis AE; Jia Q; Turner P; Mackay V; Morin CE; Triplett BM; Klein EJ; Englund JA; Tang L; Hayden RT
J Infect Dis; 2023 Aug; 228(5):627-636. PubMed ID: 37249910
[TBL] [Abstract][Full Text] [Related]
65. [Association between acute graft versus host disease and lung injury after allogenic hematopoietic stem cell transplantation].
Liu QF; Luo XD; Fan ZP; Ning J; Xu D; Sun J; Zhang Y; Xu B; Wei YQ
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):538-42. PubMed ID: 19567075
[TBL] [Abstract][Full Text] [Related]
66. Dynamics of the Gut Microbiota in Children Receiving Selective or Total Gut Decontamination Treatment during Hematopoietic Stem Cell Transplantation.
Bekker V; Zwittink RD; Knetsch CW; Sanders IMJG; Berghuis D; Heidt PJ; Vossen JMJJ; de Vos WM; Belzer C; Bredius RGM; Van't Hof PJ; Lankester AC; Kuijper EJ
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1164-1171. PubMed ID: 30731251
[TBL] [Abstract][Full Text] [Related]
67. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid.
Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB
J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237
[TBL] [Abstract][Full Text] [Related]
68. An alpha-defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft-versus-host disease.
Rashidi A; Herman A; Gomes ALC; Peled JU; Jenq RR; Brereton DG; Staley C; Blazar BR; Weisdorf DJ
Br J Haematol; 2020 Jun; 189(5):926-930. PubMed ID: 32086815
[TBL] [Abstract][Full Text] [Related]
69. Enteral versus Parenteral Nutrition as Nutritional Support after Allogeneic Hematopoietic Stem Cell Transplantation: a Systematic Review and Meta-Analysis.
Zama D; Gori D; Muratore E; Leardini D; Rallo F; Turroni S; Prete A; Brigidi P; Pession A; Masetti R
Transplant Cell Ther; 2021 Feb; 27(2):180.e1-180.e8. PubMed ID: 33830034
[TBL] [Abstract][Full Text] [Related]
70. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
Front Immunol; 2020; 11():1534. PubMed ID: 32849519
[No Abstract] [Full Text] [Related]
71. Linking gastrointestinal microbiota and metabolome dynamics to clinical outcomes in paediatric haematopoietic stem cell transplantation.
Vaitkute G; Panic G; Alber DG; Faizura-Yeop I; Cloutman-Green E; Swann J; Veys P; Standing JF; Klein N; Bajaj-Elliott M
Microbiome; 2022 Jun; 10(1):89. PubMed ID: 35689247
[TBL] [Abstract][Full Text] [Related]
72. Association between IL1B (+3954) polymorphisms and IL-1β levels in blood and saliva, together with acute graft-versus-host disease.
Resende RG; Abreu MH; de Souza LN; Silva ME; Gomez RS; Correia-Silva Jde F
J Interferon Cytokine Res; 2013 Jul; 33(7):392-7. PubMed ID: 23659674
[TBL] [Abstract][Full Text] [Related]
73. Therapeutic Effects of HLA-G5 Overexpressing hAMSCs on aGVHD After Allo-HSCT: Involving in the Gut Microbiota at the Intestinal Barrier.
Bu X; Pan W; Wang J; Liu L; Yin Z; Jin H; Liu Q; Zheng L; Sun H; Gao Y; Ping B
J Inflamm Res; 2023; 16():3669-3685. PubMed ID: 37645691
[TBL] [Abstract][Full Text] [Related]
74. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
75. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
76. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation.
Ciernikova S; Kasperova B; Drgona L; Smolkova B; Stevurkova V; Mego M
Blood Rev; 2021 Jul; 48():100790. PubMed ID: 33573867
[TBL] [Abstract][Full Text] [Related]
77. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
[TBL] [Abstract][Full Text] [Related]
78. Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Liu S; Han J; Gong H; Li Y; Bao X; Qi J; Liu H; Chen J; Wu X; Xu Y; Ma S; Wu D
Sci Rep; 2018 Jul; 8(1):10328. PubMed ID: 29985424
[TBL] [Abstract][Full Text] [Related]
79. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.
Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ
Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226
[TBL] [Abstract][Full Text] [Related]
80. Suppression of Hematopoietic Primitive Cells in Patients with Secondary Failure of Platelet Recovery after Acute Graft-versus-Host Disease.
Huang A; Zhao X; Li M; Tang G; Fei Y; Wang R; Gao L; Ni X; Zhang W; Yang J; Hu X; Wang J
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1840-1854. PubMed ID: 32534102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
